Search

Your search keyword '"Rosenkranz R"' showing total 192 results
Start Over Author "Rosenkranz R"
192 results on '"Rosenkranz R"'

1. Development and evaluation of the Capability, Opportunity, and Motivation to deliver Physical Activity in School Scale (COM-PASS)

Author

Verdonschot, A., Beauchamp, M. R., Brusseau, T. A., Chinapaw, M. J. M., Christiansen, L. B., Daly-Smith, A., Eather, N., Fairclough, S. J., Faulkner, G., Foweather, L., García-Hermoso, A., Ha, A. S., Harris, N., Jaakkola, T., Jago, R., Kennedy, S. G., Lander, N. J., Lonsdale, C., Manios, Y., Mazzoli, E., Murtagh, E., Nathan, N., Naylor, P. J., Noetel, M., O’Keeffe, B., Resaland, G. K., Ridgers, N. D., Ridley, K., Riley, N., Rosenkranz, R. R., Rosenkranz, S. K., Sääkslahti, A., Sczygiol, S. M., Skovgaard, T., van Sluijs, E. M. F., Smith, J. J., Smith, M., Stratton, G., Vidal-Conti, J., Webster, C. A., Young, E. S., and Lubans, D. R.

Published
2024
Full Text
View/download PDF

2. Schnuppe² – Seichtgang

Author

H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg and H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg

Published
2022

3. Sauerampfer – Schlangenspritze

Author

H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spanenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spanenberg and H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spanenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spanenberg

Published
2022

4. Reisigagen – Sauerampfer

Author

H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg and H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg

Published
2022

5. Plispern – quutschern

Author

H. Rosenkranz, R. Schäftlein, K. Spangenberg, H. Schrickel, H. Rosenkranz, R. Schäftlein, K. Spangenberg, H. Schrickel and H. Rosenkranz, R. Schäftlein, K. Spangenberg, H. Schrickel, H. Rosenkranz, R. Schäftlein, K. Spangenberg, H. Schrickel

Published
2022

6. R – Reisig

Author

H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg and H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg, H. Rosenkranz, R. Schäftlein, H. Schrickel, K. Spangenberg

Published
2022

7. Transdisciplinary Approaches for the Dissemination of the SWITCH School Wellness Initiative through a Distributed 4-H/Extension Network

Author

McLoughlin, G. M., Vazou, S., Liechty, L., Torbert, A., Lanningham-Foster, L., Rosenkranz, R. R., and Welk, G. J.

Abstract

Background: Schools provide an ideal setting for promoting healthy lifestyles in youth, but it has proven difficult to promote the adoption and implementation of evidence-based programming by school leaders. The SWITCH® ("School Wellness Integration Targeting Child Health") intervention is a capacity-building process designed to help school leaders learn how to plan, implement, and sustain school wellness programs on their own. Objective: The present study evaluates the transdisciplinary approaches used in establishing an integrated research-practice partnership with the state-wide 4-H/Extension network to support broader dissemination. Method: The study used a mixed methods approach to evaluate the degree of engagement and motivation of 4-H leaders (N = 30) for providing ancillary support for local school wellness programming. Engagement from 4-H Staff was logged over a year-long period through tracking completion of training and ongoing engagement with aspects of SWITCH. They completed checkpoint surveys and an interview to provide perceptions of supporting school implementation of SWITCH programming. Data were analysed through Pearson bivariate correlations and constant comparative analysis. Results: County-level 4-H staff demonstrated high engagement in SWITCH by attending training sessions and hosting structured checkpoint sessions with schools. Interview data revealed that 4-H Staff valued connections with schools and emphasized that training on SWITCH was consistent with their existing roles related to youth programming. Conclusions The results demonstrate the value of the sequential capacity-building process used to train 4-H Staff to facilitate school wellness programming. The transdisciplinary approaches built transferable skills and fostered relationships that directly support the broader goals of 4-H.

Published
2021
Full Text
View/download PDF

11. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study

Author

Bocci, Maria Grazia, Maviglia, Riccardo, Consalvo, Ludovica Maria, Domenico Luca Grieco, Montini, Luca, Mercurio, Giovanna, Nardi, G, Pisapia, Luca, L Cutuli, S, Domenico, G Biasucci, Gori, Giovanni Cristiano, Rosenkranz, R, De Candia, Erica, Carelli, Simone, Daniele, Natalini, Antonelli, Massimo, and Franceschi, Francesco

Subjects
Male, Neutrophils, coronavirus, Antithrombins, blood coagulation, Fibrin Fibrinogen Degradation Products, Leukocyte Count, respiratory insufficiency, Humans, International Normalized Ratio, Lymphocyte Count, Prospective Studies, Enoxaparin, Aged, Aged, 80 and over, Respiratory Distress Syndrome, Heparin, Platelet Count, SARS-CoV-2, Settore MED/09 - MEDICINA INTERNA, Anticoagulants, COVID-19, Fibrinogen, Blood Coagulation Disorders, Middle Aged, Thrombelastography, COVID-19 Drug Treatment, Treatment Outcome, Settore MED/41, haemostasis, Female, Partial Thromboplastin Time, Blood Coagulation Tests
Abstract

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection may yield a hypercoagulable state with fibrinolysis impairment. We conducted a single-center observational study with the aim of analyzing the coagulation patterns of intensive care unit (ICU) COVID-19 patients with both standard laboratory and viscoelastic tests. The presence of coagulopathy at the onset of the infection and after seven days of systemic anticoagulant therapy was investigated.Forty consecutive SARS-CoV-2 patients, admitted to the ICU of a University hospital in Italy between 29th February and 30th March 2020 were enrolled in the study, providing they fulfilled the acute respiratory distress syndrome criteria. They received full-dose anticoagulation, including Enoxaparin 0.5 mg·kg-1 subcutaneously twice a day, unfractionated Heparin 7500 units subcutaneously three times daily, or low-intensity Heparin infusion. Thromboelastographic (TEG) and laboratory parameters were measured at admission and after seven days.At baseline, patients showed elevated fibrinogen activity [rTEG-Ang 80.5° (78.7 to 81.5); TEG-ACT 78.5 sec (69.2 to 87.9)] and an increase in the maximum amplitude of clot strength [FF-MA 42.2 mm (30.9 to 49.2)]. No alterations in time of the enzymatic phase of coagulation [CKH-K and CKH-R, 1.1 min (0.85 to 1.3) and 6.6 min (5.2 to 7.5), respectively] were observed. Absent lysis of the clot at 30 minutes (LY30) was observed in all the studied population. Standard coagulation parameters were within the physiological range: [INR 1.09 (1.01 to 1.20), aPTT 34.5 sec (29.7 to 42.2), antithrombin 97.5% (89.5 to 115)]. However, plasma fibrinogen [512.5 mg·dl-1 (303.5 to 605)], and D-dimer levels [1752.5 ng·ml-1 (698.5 to 4434.5)], were persistently increased above the reference range. After seven days of full-dose anticoagulation, average TEG parameters were not different from baseline (rTEG-Ang p = 0.13, TEG-ACT p = 0.58, FF-MA p = 0.24, CK-R p = 0.19, CKH-R p = 0.35), and a persistent increase in white blood cell count, platelet count and D-dimer was observed (white blood cell count p0.01, neutrophil count p = 0.02, lymphocyte count p0.01, platelet count p = 0.130.01, D-dimer levels p= 0.02).SARS-CoV-2 patients with acute respiratory distress syndrome show elevated fibrinogen activity, high D-dimer levels and maximum amplitude of clot strength. Platelet count, fibrinogen, and standard coagulation tests do not indicate a disseminated intravascular coagulation. At seven days, thromboelastographic abnormalities persist despite full-dose anticoagulation.

Published
2020

20. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.

Author

BOCCI, M. G., MAVIGLIA, R., CONSALVO, L. M., GRIEGO, D. L., MONTINI, L., MERCURIO, G., NARDI, G., PISAPIA, L., CUTULI, S. L., BIASUCCI, D. G., GORI, C., ROSENKRANZ, R., DE CANDIA, E., CARELLI, S., NATALINI, D., ANTONELLI, M., and FRANCESCHI, F.

Abstract

OBJECTIVE: Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection may yield a hypercoagulable state with fibrinolysis impairment. We conducted a single-center observational study with the aim of analyzing the coagulation patterns of intensive care unit (ICU) COVID-19 patients with both standard laboratory and viscoelastic tests. The presence of coagulopathy at the onset of the infection and after seven days of systemic anticoagulant therapy was investigated. PATIENTS AND METHODS: Forty consecutive SARS-CoV-2 patients, admitted to the ICU of a University hospital in Italy between 29th February and 30th March 2020 were enrolled in the study, providing they fulfilled the acute respiratory distress syndrome criteria. They received full-dose anticoagulation, including Enoxaparin 0.5 mg⋅kg-1 subcutaneously twice a day, unfractionated Heparin 7500 units subcutaneously three times daily, or low-intensity Heparin infusion. Thromboelastographic (TEG) and laboratory parameters were measured at admission and after seven days. RESULTS: At baseline, patients showed elevated fibrinogen activity [rTEG-Ang 80.5° (78.7 to 81.5) ; TEG-ACT 78.5 sec (69.2 to 87.9)] and an increase in the maximum amplitude of clot strength [FF-MA 42.2 mm (30.9 to 49.2)]. No alterations in time of the enzymatic phase of coagulation [CKH-K and CKH-R, 1.1 min (0.85 to 1.3) and 6.6 min (5.2 to 7.5), respectively] were observed. Absent lysis of the clot at 30 minutes (LY30) was observed in all the studied population. Standard coagulation parameters were within the physiological range: [INR 1. 09 (1.01 to 1.20), aPTT 34.5 sec (29.7 to 42.2), antithrombin 97.5% (89.5 to 115)]. However, plasma fibrinogen [512.5 mgdl-1 (303.5 to 605)], and D-dimer levels [1752.5 ngml-1 (698.5 to 4434.5)], were persistently increased above the reference range. After seven days of full-dose anticoagulation, average TEG parameters were not different from baseline (rTEG-Ang p = 0.13, TEG-ACT p = 0.58, FF-MA p = 0.24, CK-R p = 0.19, CKH-R p = 0.35), and a persistent increase in white blood cell count, platelet count and D-dimer was observed (white blood cell count p < 0.01, neutrophil count p = 0.02, lymphocyte count p < 0.01, platelet count p = 0.13 < 0.01, D-dimer levels p= 0.02). CONCLUSIONS: SARS-CoV-2 patients with acute respiratory distress syndrome show elevated fibrinogen activity, high D-dimer levels and maximum amplitude of clot strength. Platelet count, fibrinogen, and standard coagulation tests do not indicate a disseminated intravascular coagulation. At seven days, thromboelasto-graphic abnormalities persist despite full-dose anticoagulation. [ABSTRACT FROM AUTHOR]

Published
2020

29. Quantification and analysis of geomorphic processes on a recultivated iron ore mine on the Italian island Elba using long-time ground-based LIDAR and photogrammetric data by an UAV

Author

Haas, F., primary, Hilger, L., additional, Neugirg, F., additional, Umstädter, K., additional, Breitung, C., additional, Fischer, P., additional, Hilger, P., additional, Heckmann, T., additional, Dusik, J., additional, Kaiser, A., additional, Schmidt, J., additional, Della Seta, M., additional, Rosenkranz, R., additional, and Becht, M., additional

Published
2015
Full Text
View/download PDF

40. QUALITY OF LIFE/AFTERCARE

Author

Rednam, S., primary, Scheurer, M., additional, Adesina, A., additional, Lau, C., additional, Okcu, M., additional, Deatrick, J., additional, Ogle, S., additional, Fisher, M., additional, Barakat, L., additional, Hardie, T., additional, Li, Y., additional, Ginsberg, J., additional, Ben-Arush, M., additional, Krivoy, E., additional, Rosenkranz, R., additional, Peretz-Nahum, M., additional, Brown, R. J., additional, Love, J., additional, Warburton, D., additional, McBride, W. H., additional, Bluml, S., additional, Mueller, S., additional, Sear, K., additional, Hills, N., additional, Chettout, N., additional, Afghani, S., additional, Lew, L., additional, Tolentino, E., additional, Haas-Kogan, D., additional, Fullerton, H., additional, Reddick, W., additional, Palmer, S., additional, Glass, J., additional, Ogg, R., additional, Gajjar, A., additional, Omar, A., additional, Perkins, S., additional, Shinohara, E., additional, Spoljaric, D., additional, Isenberg, J., additional, Whittington, M., additional, Hauff, M., additional, King, A., additional, Litzelman, K., additional, Barker, E., additional, Catrine, K., additional, Puccetti, D., additional, Possin, P., additional, Witt, W., additional, Mallucci, C., additional, Kumar, R., additional, Pizer, B., additional, Williams, D., additional, Pettorini, B., additional, Piscione, J., additional, Bouffet, E., additional, Shams, I., additional, Kulkarni, A., additional, Remes, T., additional, Harila-Saari, A., additional, Suo-Palosaari, M., additional, Arikoski, P., additional, Riikonen, P., additional, Sutela, A., additional, Koskenkorva, P., additional, Ojaniemi, M., additional, Rantala, H., additional, Campen, C. J., additional, Ashby, D., additional, Fisher, P. G., additional, Monje, M., additional, Kulkarni, A. V., additional, Nakamura, H., additional, Makino, K., additional, Yano, S., additional, Kuratsu, J.-i., additional, Jadrijevic-Cvrlje, F., additional, Batinica, M., additional, Toledano, H., additional, Hoffman, T., additional, Ezer-Cohen, Y., additional, Michowiz, S., additional, Yaniv, I., additional, Cohen, I. J., additional, Adler, I., additional, Mindel, S., additional, Gopalakrishnamoorthy, M., additional, Saunders, D., additional, Gaze, M., additional, Spoudeas, H., additional, Kieffer, V., additional, Dellatolas, G., additional, Chevignard, M., additional, Puget, S., additional, Dhermain, F., additional, Grill, J., additional, Dufour, C., additional, Muir, R., additional, Hunter, A., additional, Latchman, A., additional, de Camargo, O., additional, Scheinemann, K., additional, Dhir, N., additional, Zaky, W., additional, Zomorodian, T., additional, Wong, K., additional, Dhall, G., additional, Macy, M., additional, Lauro, C., additional, Zeitler, P., additional, Foreman, N., additional, Liu, A., additional, Chocholous, M., additional, Dodier, P., additional, Peyrl, A., additional, Dieckmann, K., additional, Hausler, G., additional, Slavc, I., additional, Avula, S., additional, Garlick, D., additional, Armstrong, G., additional, Kawashima, T., additional, Leisenring, W., additional, Stovall, M., additional, Sklar, C., additional, Robison, L., additional, Samaan, C., additional, Duckworth, J., additional, Greenberg-Kushnir, N., additional, Freedman, S., additional, Eshel, R., additional, Zverling, N., additional, Elhasid, R., additional, Dvir, R., additional, Yalon, M., additional, Constantini, S., additional, Wilne, S., additional, Liu, J.-F., additional, Trusler, J., additional, Lundsell, S., additional, Kennedy, C., additional, Clough, L., additional, Dickson, N., additional, Lakhanpaul, M., additional, Baker, M., additional, Dudley, J., additional, Grundy, R., additional, Walker, D., additional, von Hoff, K., additional, Herzog, N., additional, Ottensmeier, H., additional, Grabow, D., additional, Gerber, N. U., additional, Friedrich, C., additional, von Bueren, A. O., additional, Resch, A., additional, Kortmann, R. D., additional, Kaatsch, P., additional, Doerr, H. G., additional, Rutkowski, S., additional, del Bufalo, F., additional, Mastronuzzi, A., additional, Serra, A., additional, de Sio, L., additional, Locatelli, F., additional, Biassoni, V., additional, Leonardi, M., additional, Ajovalasit, D., additional, Riva, D., additional, Vago, C., additional, Usilla, A., additional, Fidani, P., additional, Schiavello, E., additional, Gariboldi, F., additional, Massimino, M., additional, Lober, R., additional, Perrault, S., additional, Partap, S., additional, Edwards, M., additional, Fisher, P., additional, Yeom, K., additional, Salgado, D., additional, Nunes, S., additional, Vinhais, S., additional, Wells, E. M., additional, Seidel, K., additional, Ullrich, N. J., additional, Diller, L., additional, Krull, K. R., additional, Neglia, J., additional, Robison, L. L., additional, Whelan, K., additional, Russell, C. E., additional, Brownstone, D., additional, Kaise, C., additional, Bull, K., additional, Culliford, D., additional, Calaminus, G., additional, Bertin, D., additional, Vallero, S., additional, Romano, E., additional, Basso, M. E., additional, Biasin, E., additional, Fagioli, F., additional, Ziara, K., additional, L'Hotta, A., additional, Williams, A., additional, Thede, R., additional, Moore, K., additional, James, A., additional, Bjorn, E., additional, Franzen, P., additional, Haag, A., additional, Lax, A.-K., additional, Moreno, I., additional, Obeid, J., additional, Timmons, B. W., additional, Iwata, W., additional, Wagner, S., additional, Lai, J.-S., additional, Waddell, K., additional, VanLeeuwen, S., additional, Newmark, M., additional, Noonan, J., additional, O'Connell, K., additional, Urban, M., additional, Yount, S., additional, Goldman, S., additional, Igoe, D., additional, Cunningham, T., additional, Orfus, M., additional, Mabbott, D., additional, Liptak, C., additional, Manley, P., additional, Recklitis, C., additional, Zhang, P., additional, Shaikh, F., additional, Narang, I., additional, Matsumoto, K., additional, Yamasaki, K., additional, Okada, K., additional, Fujisaki, H., additional, Osugi, Y., additional, Hara, J., additional, Phipps, K., additional, Gumley, D., additional, Jacques, T., additional, Hargrave, D., additional, Michalski, A., additional, Chordas, C., additional, Chi, S., additional, Robison, N., additional, Bandopadhayay, P., additional, Marcus, K., additional, Zimmerman, M. A., additional, Goumnerova, L., additional, Kieran, M., additional, Brand, S., additional, Brinkman, T., additional, Delaney, B., additional, Diver, T., additional, Rey, C., additional, Madden, J. R., additional, Hemenway, M. S., additional, Dorneman, L., additional, Stiller, D., additional, Liu, A. K., additional, Foreman, N. K., additional, Vibhakar, R., additional, Mitchell, M., additional, Hemenway, M., additional, Madden, J., additional, Ryan, M., additional, O'Kane, R., additional, Picton, S., additional, Kenny, T., additional, Stiller, C., additional, Chumas, P., additional, Bendel, A., additional, Patterson, R., additional, Barrera, M., additional, Schulte, F., additional, Bartels, U., additional, Janzen, L., additional, Johnston, D., additional, Cataudella, D., additional, Chung, J., additional, Sung, L., additional, Hancock, K., additional, Hukin, J., additional, Zelcer, S., additional, Brandon, S., additional, Montour-Proulx, I., additional, Strother, D., additional, Cooksey, R., additional, Bowers, D., additional, Gargan, L., additional, Gode, A., additional, Klesse, L., additional, Oden, J., additional, Vega, G., additional, Sala, F., additional, Nuzzi, D., additional, Mulino, M., additional, Masotto, B., additional, Mazza, C., additional, Bricolo, A., additional, Gerosa, M., additional, Tong, M., additional, Laughlin, S., additional, Mackie, S., additional, Taylor, L., additional, Sharpe, G., additional, Al-Salihi, O., additional, and Nicolin, G., additional

Published
2012
Full Text
View/download PDF

41. Active Alone or With Others: Does It Matter for Children With Autism Spectrum Disorder?

Author

Schenkelberg, M. A., Rosenkranz, R. R., Milliken, G. A., and Dzewaltowski, D. A.

Subjects
*PHYSICAL activity, *AUTISM spectrum disorders in children, *SOCIAL context, *SOCIAL groups, *AGE groups
Abstract

The article focuses on a study related to effect of setting and social group composition on physical activity levels of children with autism spectrum disorder (ASD) who participated in a summer camp. Topics discussed include researchers who hypothesized that children with ASD would have lower levels of physical activity than those without ASD; impact of social environment on ASD children; and study that reveal increased physical activity during free play for ASD children, when in peers.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results